One of the most important unanswered questions is how the first prion-like seed arises de novo, resulting in the pathological cascade.
P
rions are protein conformations that "self-seed" the misfolding of their non-prion iso-forms into prion, often amyloid, conformations. The most famous prion is the mammalian PrP protein that in its prion form causes transmissible spongiform encephalopathy. Curiously there can be distinct conformational differences even between prions of the same protein propagated in the same host species. These are called prion strains or variants. For example, different PrP variants are faithfully transmitted during self-seeding and are associated with distinct disease characteristics. Variant-specific PrP prion differences include the length of the incubation period before the disease appears and the deposition of prion aggregates in distinct regions of the brain. 1 Other more common neurodegenerative diseases (e.g., Alzheimer disease, Parkinson disease, type 2 diabetes and ALS) are likewise caused by the misfolding of a normal protein into a self-seeding aggregate.
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Our recent article uses a yeast model system to investigate the hypothesis that one prion aggregate cross-seeds the de novo aggregation of a heterologous protein. 5 In support of the hypothesis we find that different prion variants of one yeast protein preferentially promote the de novo appearance of different prion variants of a heterologous yeast protein. This would be expected if the shapes of the cross-seeding prion variants preferentially converted the heterologous prion protein into variants with conformations similar to themselves.
In this article addendum we show that the preferential induction of specific prion variants depends not only of the variant of the cross-seeding prion, but also upon the temperature of incubation during the cross-seeding.
The Yeast Model System
[PSI + ] is the prion form of the translational release factor, Sup35. 6 Support for the chaperone titration model has come from the findings that amyloid aggregates bind to and titrate chaperones away from the cytosol. [29] [30] [31] It is also possible that both mechanisms contribute to the increased de novo appearance of the heterologous prion.
In our recent article we investigated why some [ Table 1 ). [20] [21] [22] [23] [24] The frequency of the cross-seeding was proposed to be much less efficient than self-seeding, and to depend on the conformation of the specific [PIN + ] prion variant used. 19, 25 Another possibility also proposed 21, 26 is that the [PIN + ] prion aggregate binds to a prion inhibitor, titrating it away from the cytosol resulting in the more frequent conversion to the prion state.
Testing the Mechanism of Variant-Specific Cross-Seeding Efficiencies
Support for the cross-seeding model comes from in vitro demonstrations that prion fibers can promote the aggregation Interestingly, the environment also influences the type of variant formed in vivo. We demonstrated this in this addendum by altering the incubation temperature. Other cellular stressors may also influence the type of prion variant induced. If so the environment could preferentially induce prions that provide an advantage in the stress condition.
These findings are likely to be relevant to the de novo formation of amyloid aggregates of specific proteins associated with other neurodegenerative diseases. [2] [3] [4] Whether amyloid aggregates of a single protein can always form distinct variants associated with different disease characteristics remains to be determined. Evidence already hints that disease associated amyloid aggregates can cross-seed the de novo appearance of amyloid aggregates associated with a different disease.
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suggests that variant differences occur at the second step of cross-seeding. Indeed, different [ 34 In contrast, once fibers are formed, they seed the formation of fibers with their variant specificity despite the incubation temperature.
Here were show that temperature also exerts a strong effect in vivo on the variants of [ Figure 1 and previously proposed to explain the in vitro results. 35 Whatever the case, it is clear that both intra-and extracellular factors influence the frequency of induction of specific heterologous prion variants. While the work shown here is specific for effects of temperature, other stresses on the cell such as oxidative stress my also influence the preference for the appearance of specific prion variants. Since variants have different effects on the cells, the environment could select for variants that promote survival.
Discussion
The data presented in our recent article 5 supports the cross-seeding model and ] and inactivation of the Sup35, translational release factor. red sectoring colonies were subcloned before scoring.
